Combined HRT increases risk of lobular breast cancer fourfold after just 3 years of use

Postmenopausal women who take combined estrogen/progestin hormone-replacement therapy for three years or more face a fourfold increased risk of developing various forms of lobular breast cancer, according to new findings by researchers at Fred Hutchinson Cancer Research Center.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news119598157.html">Combined HRT increases risk of lobular breast cancer fourfold after just 3 years of use</a></p> <p>Postmenopausal women who take combined estrogen/progestin hormone-replacement therapy for three years or more face a fourfold increased risk of developing various forms of lobular breast cancer, according to new findings by researchers at Fred Hutchinson Cancer Research Center.</p>